Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

Similar documents
Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 2 Understanding the spread

Multi-Drug Resistant Organisms (MDRO)

Basics of Antibiotic resistance: Focus on Carbapenem-resistant Enterobacteriaceae

What bugs are keeping YOU up at night?

Kevin B. Spicer, MD, PhD, MPH Antibiotic Resistance Coordinator, HAI/AR Program Kentucky Department for Public Health

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

Two (II) Upon signature

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Infectious Disease in PA/LTC an Update. Karyn P. Leible, MD, CMD, FACP October 2015

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA

Infection Control & Prevention

Risk of organism acquisition from prior room occupants: A systematic review and meta analysis

Core Elements of Antibiotic Stewardship for Nursing Homes

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

New Drugs for Bad Bugs- Statewide Antibiogram

Horizontal vs Vertical Infection Control Strategies

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Hospital Acquired Infections in the Era of Antimicrobial Resistance

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

Objectives. Basic Microbiology. Patient related. Environment related. Organism related 10/12/2017

Other Enterobacteriaceae

Summary of the latest data on antibiotic resistance in the European Union

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Antimicrobial Resistance. The Case for Diagnostics to Better Direct Therapy

4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY

Infection Control of Emerging Diseases

Rise of Resistance: From MRSA to CRE

Human health impacts of antibiotic use in animal agriculture

ANTIBIOTIC RESISTANCE THREATS. in the United States, 2013

TABLE OF CONTENTS Foreword...5 Executive Summary...6 Section 1: The Threat of Antibiotic Resistance...11 Introduction...11 National Summary Data...

Cipro for gram positive cocci in urine

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC

Healthcare-associated Infections Annual Report December 2018

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

ANTIMICROBIAL STEWARDSHIP IN LONG TERM CARE FACILITIES

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium

Service Delivery and Safety Department World Health Organization, Headquarters

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

Surveillance of Multi-Drug Resistant Organisms

Public Health Response to Emerging Resistance

RCH antibiotic susceptibility data

Multidrug-resistant Organisms (MDROs): Is the Future to be Feared? Multi-drug Resistant Organisms (MDROs)

Presented by: Mary McGoldrick, MS, RN, CRNI

What s next in the antibiotic pipeline?

Antimicrobial Cycling. Donald E Low University of Toronto

Get Smart For Healthcare

INFECTION PREVENTION SILVER ANTI-MICROBIAL TEXTILES

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Prevention, Management, and Reporting of Carbapenem-Resistant Enterobacteriaceae

ANTIMICROBIAL STEWARDSHIP: THE ROLE OF THE CLINICIAN SAM GUREVITZ PHARM D, CGP BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES

Appropriate antimicrobial therapy in HAP: What does this mean?

Control of Multidrug-resistant Organisms in a Hospital Environment: Multidimensional Approach

Antimicrobial Stewardship: Setting minimum expectations for optimizing antimicrobial use and addressing resistance

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

Antibiotic Stewardship in the Hospital Setting

Using Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and

Antimicrobial Stewardship:

Preventing Clostridium difficile Infection (CDI)

The Rise of Antibiotic Resistance: Is It Too Late?

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats

Antibiotic Stewardship in LTC What does this mean?

MDRO in LTCF: Forming Networks to Control the Problem

Antibiotic Stewardship in the LTC Setting

Is biocide resistance already a clinical problem?

Antibiotic Stewardship In Post Acute and Long Term Care 2017

Antibiotic stewardship in long term care

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Collecting and Interpreting Stewardship Data: Breakout Session

WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

MICRO-ORGANISMS by COMPANY PROFILE

Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland

Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Mike Apley Kansas State University

CONTAGIOUS COMMENTS Department of Epidemiology

Other Beta - lactam Antibiotics

Testimony of the Natural Resources Defense Council on Senate Bill 785

SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data

Transcription:

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms Nimalie D. Stone, MD,MS Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion

Presentation Objectives Brief review of multidrug-resistant organisms (MDROs) and C. difficile Understand the emergence and spread of MDROs and C. difficile in healthcare settings Outline the actions that caregivers should take to minimize the spread of MDROs and C. difficile Describe national programs developed to support nursing home infection prevention programs in tracking and preventing MDROs and C. difficile.

Basics on bacteria Gram Stain Positive (purple) Gram Stain Negative (pink/red) Bacteria have different characteristics that allow us to identify them in the lab Shape, size, growth patterns, etc. We often use these characteristics to develop antibiotics

Common bacteria in healthcare Gram positive Most are cocci, round bacteria Examples are Streptococci, Staphylococci, Enterococci Clostridium difficile (C. diff) is a Gram positive rod Gram negative Most are baccili, rod-shaped bacteria Examples are: E. coli, Klebsiella, Enterobacter, Proteus Pseudomonas

Antibiotics 101 Antibiotics are drugs that treat and kill bacteria They are grouped into classes based on their structure and activity Narrow-spectrum target a few specific bacteria Broad-spectrum can kill a wide variety of bacteria Antibiotic resistance = when the bacteria are no longer fully killed by the antibiotic Bacteria with resistance can cause patients to have more severe infections which are harder and more costly to treat Infection prevention programs track certain bug-drug combinations for resistance

Understanding multidrug-resistance Multidrug-resistant organisms (MDROs) are a group of bacteria with important resistance patterns Sometimes just one key drug will define a MDRO Methicillin-resistance in Staphylococcus aureus Vancomycin-resistance in Enterococcus sp. Sometimes bacteria acquire resistance to several classes of antibiotics, often seen in gram negative rods Carbapenem-resistance in E. coli/klebsiella sp. is associated with resistance to many other antibiotics Pseudomonas can be resistant to fluoroquinolones, penicillins, cephalosporins, and carbapenems

ABC s of MDROs Bacteria Abbrev. Antibiotic Resistance Staphylococcus aureus MRSA Methicillin-resistant Enterococci (faecalis/faecium) Enterobacteriaceae (e.g., E coli/klebsiella) Enterobacteriaceae (e.g., E coli/klebsiella) Pseudomonas/ Acinetobacter VRE ESBL CRE MDR Vancomycin-resistant Extended-spectrum betalactamase (resistance to penicillins/cephalosporins) Carbapenem-resistant Resistance to multiple drug classes

NHs are reservoirs of MDROs NH residents colonized with MDR-Gram Negative Rods (~20% prevalence) O Fallon et al. Infect Control Hosp Epidemiol 2009; 30: 1172-1179 NH residents colonized with MRSA (40-50% prevalence) Mody et al. Clin Infect Dis 2008; 46(9): 1368-73 Stone et al. Infect Control Hosp Epidemiol 2012; 33(6): 551-7 NH residents colonized with VRE (5-10% prevalence) Pop-Vicas et al J Am Geriatr Soc. 2008 56(7):1276-80 Benenson et al. Infect Control Hosp Epidemiol. 2009 30:786-9

Clostridium difficile Gram positive bacillus under microscope Cannot multiple when oxygen is in the environment (anaerobic) Forms spores to survive in the environment Infections are more severe in older adults Common cause of acute diarrhea in nursing homes Higher rates of hospitalizations and relapses Spores contaminate the environment of people with active diarrheal infections Spread to other people on hands of caregivers or shared equipment Healthy colon C. difficilecolitis

More than half of healthcare associated CDI cases occur in long-term care facilities A significant number of individuals admitted to LTC are colonized with C. difficile Up to 20% acquire it while in nursing homes Fluoroquinolone antibiotics have been associated with CDI with a more severe strain of C. difficile Longer antibiotic exposure carries higher risk

C. difficile infections with onset in nursing homes >100,000 cases of CDI occur in NHs each year Up to 75% of residents with NH-onset CDI received antibiotics ~80% occurred within 30-days of hospital discharge 18% were hospitalized 8% died within 30-days of event Hunter et al. Open Forum Infect Dis. 2016 18;3(1):ofv196

Summary Points Antibiotic resistant bacteria and C. difficile are a growing problem in healthcare The large reservoir of MDRO and C. difficile found within nursing homes can become a source of transmission The population entering nursing homes have many risk factors which make them vulnerable to colonization and infection with these organisms

Thank you!! Email: nstone@cdc.gov with questions/comments For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA 30333 Telephone, 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348 E-mail: cdcinfo@cdc.gov Web: www.cdc.gov The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion